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Thorsten Wittwer, MD, PhD, Johannes M. Albes, MD, PhD, Antonia Fehrenbach, PhD,
Thomas Pech, MS, Ulrich F. W. Franke, MD, Joachim Richter, MD, PhD, and
Thorsten Wahlers, MD, PhD, Jena and Go¨ttingen, Germany
Perfadex solution provides excellent lung preservation in contrast to Euro-Collins solution.
Supplementation of the NO pathway by adding nitroglycerin to Perfadex solution can further
optimize postischemic lung function by providing beneficial dilatory effects to the pulmonary
vasculature and might therefore represent an easily applicable tool in clinical lung
transplantation.
1217 Myocardial viability twenty-four hours after orthotopic heart
transplantation from non–heart-beating donors
Juergen Martin, MD, Georg Lutter, MD, Christian Ihling, MD, Matthias Siepe, MD,
Susanne Wagner, BS, Jan Hilberath, MD, Michael Kemper, MD, Koppany Sarai, MD, and
Friedhelm Beyersdorf, MD, Freiburg, Germany
Hearts from non–heart-beating donors were transplanted orthotopically in a pig model. After 24
hours, contractility had recovered to baseline values, and regional myocardial blood flow was
increased versus baseline values. Myocardial oxygen consumption remained unchanged.
Histologic examination revealed only a few irreversibly damaged myocytes.
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1229 Midterm results after restoration of the morphologically left ventricle to the
systemic circulation in patients with congenitally corrected transposition of
the great arteries
Stephen M. Langley, MD, FRCS (CTh), David S. Winlaw, FRACS, Oliver Stumper, MD,
Rami Dhillon, MRCP, Joseph V. de Giovanni, FRCP, John G. Wright, FRCP, Paul Miller,
MRCP, Babulal Sethia, FRCS, David J. Barron, MD, FRCS (CTh), and William J. Brawn,
FRCS, FRACS, Birmingham, United Kingdom
Fifty-four patients underwent anatomic correction of congenitally corrected transposition of the
great arteries. Early mortality was 5.6%, and 9-year was survival was 89.7%, with 94% of
survivors in New York Heart Association functional class I. Continued surveillance is necessary
to determine the functions of the aortic valve and of the morphologically left ventricle in the
systemic circulation.
1242 Cardioprotective effects and the mechanisms of terminal warm blood
cardioplegia in pediatric cardiac surgery
Yoshiya Toyoda, MD, Masahiro Yamaguchi, MD, Naoki Yoshimura, MD, Shigeteru Oka, MD,
and Yutaka Okita, MD, Kobe, Japan
We evaluated the cardioprotective effects and the mechanisms of terminal warm blood
cardioplegia in 103 consecutive pediatric patients in a prospective randomized manner.
Terminal warm blood cardioplegia enhances myocardial protection in pediatric heart surgery by
improvement in aerobic energy metabolism and reduction of myocardial injury or necrosis.
1252 The modified Fontan procedure: Early and late results in 132 adult patients
Harold M. Burkhart, MD, Joseph A. Dearani, MD, Douglas D. Mair, MD, Carole A. Warnes,
MD, Charles C. Rowland, Hartzell V. Schaff, MD, Francisco J. Puga, MD, and
Gordon K. Danielson, MD, Rochester, Minn
In properly selected adult patients with functional single ventricle, the modified Fontan
procedure can be performed with early mortality similar to younger patients. Early mortality is
more likely with complex lesions. The majority of late survivors have a good quality of life.
1260 Procoagulant and anticoagulant factor abnormalities following the Fontan
procedure: Increased factor VIII may predispose to thrombosis
Kirsten C. Odegard, MD, Francis X. McGowan, Jr, MD, David Zurakowski, PhD, James A.
DiNardo, MD, Robert A. Castro, MT, Pedro J. del Nido, MD, and Peter C. Laussen, MBBS,
Boston, Mass
Pro- and anticoagulant factor abnormalities were demonstrated in patients with single ventricle
cardiac defects after the Fontan procedure, including significantly elevated factor VIII, which
could be an independent risk factor for thromboembolism.
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1268 Myocardial apoptosis after cardioplegic arrest in the neonatal lamb
James M. Hammel, MD, Christopher A. Caldarone, MD, Timothy L. Van Natta, MD,
Li Xing Wang, MD, PhD, Karl F. Welke, MD, Weigen Li, MD, PhD, Scott Niles, BA,
Elise Barner, MAT, BA, Thomas D. Scholz, MD, Douglas M. Behrendt, MD, and
Jeffrey L. Segar, MD, Iowa City, Iowa
Increased myocardial apoptosis was observed in neonatal lambs after cold hyperkalemic
cardioplegic arrest. An altered balance of proapoptotic and antiapoptotic mediators was
observed.
1276 Induced fibrillation is equally effective as crystalloid cardioplegia in the
protection of fetal myocardial function
Sunil P. Malhotra, MD, Stephan Thelitz, MD, R. Kirk Riemer, PhD, V. Mohan Reddy, MD,
Sam Suleman, BS, and Frank L. Hanley, MD, Stanford, Calif
Fetal cardiac surgery holds promise for the treatment of lesions that increase in complexity as a
result of pathologic blood-flow patterns during development. However, strategies to protect the
fetal myocardium have not been studied. In this study normothermic fibrillation and
hypothermic cardioplegia were found to provide equivalent levels of fetal myocardial
protection.
1283 Novel technique for isolated accessory right heart transplantation for
congenital heart disease
John Elefteriades, MD, Costantinos Lovoulos, MD, Randolph Edwards, MD, Shawn Tittle, MD,
Timothy Riley, MD, Paul Tang, MD, Edward Rocco, CCP, and Gary Kopf, MD, New Haven,
Conn
A novel technique is reported for transplanting an isolated donor right heart to supplement a
complete recipient heart. The technique proved technically feasible and hemodynamically
successful in short-term animal experiments. This technique might potentially represent a new
alternative for treatment of congenital obstructive or hypoplastic lesions of the right heart in
human children.
1291 Late recovery of atrioventricular conduction after pacemaker implantation
for complete heart block associated with surgery for congenital heart disease
Anjan S. Batra, MD, Winfield J. Wells, MD, Kathy W. Hinoki, RN, MSN, Robert A. Stanton,
MD, and Michael J. Silka, MD, Los Angeles, Calif
Late recovery of AV conduction occurred in 7 of 72 patients who had undergone pacemaker
implantation for complete heart block after surgery for congenital heart disease. Once
conduction had returned, recurrence of heart block was not observed, suggesting that lifelong
permanent pacing may not be necessary.
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